Conference Coverage

Alcohol-related liver disease severity increased during COVID-19 pandemic


 

AT ACG 2021

More robust support needed

“This highlights that the increase in alcohol use seems to be associated with higher rates of more severe alcoholic hepatitis, and we are going to need to all be aware of and intervene in these individuals, and try to not only make health care more accessible, but help those with alcohol use disorder to reengage in some support systems [and] harm-reduction measures, to try to reduce the number of these episodes of admissions with severe alcoholic hepatitis,” said Paul Kwo, MD, who comoderated the session. Dr. Kwo is a professor of medicine at Stanford (Calif.) University.

Dr. Paul Y. Kwo

Dr. Paul Y. Kwo

Dr. Kwo suggested that the pandemic has presented dual challenges to patients with alcohol-related liver disease. One is that hospitals have filled up because of an influx of COVID-19 cases, which makes it hard for them to compete for limited resources. The other is that lockdowns and social interruptions may have interfered with the support systems that normally help them to keep sober and maintain health care. “The pandemic really disrupted everybody’s ecosystem substantially, and some of these individuals, as their ecosystems crumble, they don’t have other resources to engage in care, and then they present with far more advanced comorbidities than we might have seen prior to the pandemic,” said Dr. Kwo.

The findings underscore at least one lesson that can be drawn from the pandemic. “We now know that we have to develop more robust systems to provide support for all of these individuals,” said Dr. Kwo.

Comoderator Patricia D. Jones, MD, agreed, and expressed optimism. “We were forced develop more remote or virtual networks, so I think there are a lot of people that are taking advantage maybe of virtual [Alcoholics Anonymous], and that wasn’t something that they necessarily did [before the pandemic]. And so at least we’ve developed some parallel systems that hopefully people will benefit from,” said Dr. Jones, who is an assistant professor of medicine at the University of Miami.

She suggested that physicians should make inquiries about patients with alcohol-related liver disease and their social situations, and might consider trying to connect them to a social worker if called for. “I think that really speaking to the person about where they are would be beneficial,” said Dr. Jones.

Dr. Sobotka, Dr. Jain, Dr. Kwo, and Dr. Jones have no relevant financial disclosures.

Pages

Recommended Reading

AGA Clinical Practice Update: Expert Review on IBD dysplasia surveillance, management
Journal of Clinical Outcomes Management
How do alcohol, obesity impact cirrhosis?
Journal of Clinical Outcomes Management
Improving Physicians’ Bowel Documentation on Geriatric Wards
Journal of Clinical Outcomes Management
AGA Clinical Practice Update: Expert review on GI perforations
Journal of Clinical Outcomes Management
Better COVID-19 outcomes confirmed in TNF inhibitor users
Journal of Clinical Outcomes Management
Immune response detected in most IBD patients after COVID vaccines
Journal of Clinical Outcomes Management
AGA Clinical Practice Guideline: Coagulation in cirrhosis
Journal of Clinical Outcomes Management
AGA Clinical Practice Update: Managing pain in gut-brain interaction disorders
Journal of Clinical Outcomes Management
Obesity interventions tied to colon cancer risk reduction
Journal of Clinical Outcomes Management
Risankizumab has early and lasting benefits in Crohn’s disease
Journal of Clinical Outcomes Management